RLYB - Rallybio - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-38.71M

Cash

94.18M

Avg Qtr Burn

-14.24M

Short % of Float

2.62%

Insider Ownership

4.06%

Institutional Own.

73.95%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RLYB212 Details Fetal and Neonatal Alloimmune Thrombocytopenia	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RLYB116 Details Myasthenia gravis, Paroxysmal nocturnal hemoglobinuria	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RLYB211 Details Fetal and Neonatal Alloimmune Thrombocytopenia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.